Vimarsana
Biggest News Aggregation in the World

Page 5 - Evoke Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evoke Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evoke Pharma Today - Breaking & Trending Today

StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK) - Vimarsana News

StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK)

StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report published on Sunday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Up 4.2 % Shares of NASDAQ:EVOK opened at $1.26 on Friday. The company has a market capitalization of $4.21 million, a P/E […]

Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray - Vimarsana News

Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray

Evoke Pharma (NASDAQ:EVOK) CEO Dave Gonyer joined Steve Darling from Proactive to share news the company has achieved a significant milestone with the...

Analysts' New Coverage for November 26th (AIRG, AJX, AMS, APVO, CCF, CNET, CORR, CVR, DLNG, EVOK) - Vimarsana News

Analysts' New Coverage for November 26th (AIRG, AJX, AMS, APVO, CCF, CNET, CORR, CVR, DLNG, EVOK)

Analysts’ new coverage for Sunday, November 26th: StockNews.com began coverage on shares of Airgain (NASDAQ:AIRG). The firm issued a hold rating on the stock. StockNews.com initiated coverage on shares of Great Ajax (NYSE:AJX). The firm issued a sell rating on the stock. StockNews.com started coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS). They issued […]

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report released on Saturday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Price Performance Evoke Pharma stock opened at $1.21 on Friday. Evoke Pharma has a 52 week low of $0.92 and a 52 […]

Evoke Pharma : Failure to Satisfy Listing Rule - Form 8-K -November 22, 2023 at 04:18 pm EST - Vimarsana News

Evoke Pharma : Failure to Satisfy Listing Rule - Form 8-K -November 22, 2023 at 04:18 pm EST

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously announced, on May 24, 2023, Evoke...